CRISPR/Cas9 targeting HIV-1 regulatory genes inactivates latent proviral DNA and prevents new infection in T cell culture with inhibition of viral escape
Y. Ophinni,
M. Inoue,
T. Kotaki,
M. Kameoka,
Y. Hayashi
Affiliations
Y. Ophinni
Kobe University, Division of Molecular Medicine & Medical Genetics, Kobe, Japan
M. Inoue
Kobe University, Department of International Health, Graduate School of Health Sciences, Kobe, Japan
T. Kotaki
Kobe University, Department of International Health, Graduate School of Health Sciences, Kobe, Japan
M. Kameoka
Kobe University, Department of International Health, Graduate School of Health Sciences, Kobe, Japan
Y. Hayashi
Kobe University, Division of Molecular Medicine & Medical Genetics, Kobe, Japan